Tag: BioMed Realty

Blackstone portfolio company BioMed Realty received planning approval to deliver 600,000 square feet of purpose-built laboratory space in Cambridge, UK. The company will deliver...

BioMed Realty has made its second investment in Seattle this quarter with the acquisition of 1101 Westlake, the 154,000-square-foot lab capable building located in...

BioMed Realty, a Blackstone portfolio company, has acquired Denny Park South site in Seattle, Washington. Denny Park South site represents more than 600,000 square-feet...

Blackstone portfolio company BioMed Realty has acquired Cambridge International Technology Park (CITP), a 15-acre site on Fulbourn Road, from Abstract, and a 27-acre land...

BioMed Realty, a leading provider of real estate solutions for the life science and technology industries, has acquired two adjacent parcels from Clise Properties...

CIM Group, in partnership with Nordblom Company, has sold two Class A office towers, 1000 Washington St. and 321 Harrison Ave., in Boston to funds...

BioMed Realty, a Blackstone portfolio company, has received development approval from the City to expand its Emeryville Center of Innovation campus. Plans for the...

Blackstone portfolio company BioMed Realty has acquired an existing 162,000 square foot office building and adjacent 7.5 acre site at Assembly Square in Somerville,...

BioMed Realty has acquired the former John Hancock’s corporate headquarters at 601 Congress Street in Boston, Massachusetts. BioMed Realty plans to convert the office building...

Blackstone today announced that Blackstone Real Estate Partners VIII L.P. and co-investors have completed their previously announced transaction to sell BioMed Realty, a life...